Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity

C. Plasencia, E.L. Kneepkens, G. Wolbink, C.L.M. Krieckaert, S. Turk, V. Navarro-Compan, M. L'Ami, M.T. Nurmohamed, I.E. van der Horst-Bruinsma, T. Jurado, C. Diego, G. Bonilla, A. Villalba, D. Peiteado, L. Nuno, D. van der Kleij, T. Rispens, E. Martin-Mola, A. Balsa, D. Pascual-Salcedo

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1638-1646
JournalJournal of Rheumatology
Volume42
Issue number9
DOIs
Publication statusPublished - 2015

Cite this

Plasencia, C., Kneepkens, E. L., Wolbink, G., Krieckaert, C. L. M., Turk, S., Navarro-Compan, V., ... Pascual-Salcedo, D. (2015). Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity. Journal of Rheumatology, 42(9), 1638-1646. https://doi.org/10.3899/jrheum.141128